• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤表达的免疫检查点B7x促进癌症进展、抗原特异性CD8 T细胞耗竭以及抑制性固有免疫细胞。

Tumor-expressed immune checkpoint B7x promotes cancer progression and antigen-specific CD8 T cell exhaustion and suppressive innate immune cells.

作者信息

Ohaegbulam Kim C, Liu Weifeng, Jeon Hyungjun, Almo Steven C, Zang Xingxing

机构信息

Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY, USA.

Department of Biochemistry, Albert Einstein College of Medicine, Bronx, NY, USA.

出版信息

Oncotarget. 2017 Sep 20;8(47):82740-82753. doi: 10.18632/oncotarget.21098. eCollection 2017 Oct 10.

DOI:10.18632/oncotarget.21098
PMID:29137299
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5669925/
Abstract

B7x (B7-H4 or B7S1) is a coinhibitory member of the B7 immune checkpoint ligand family that regulates immune function following ligation with its unknown cognate receptors. B7x has limited expression on normal tissues, but is up-regulated on solid human tumors to inhibit anti-tumor immunity and associates with poor clinical prognosis. We assessed the contribution of cytokine stimuli to induce surface B7x expression on cancer cells and the role of tumor-expressed B7x in a murine pulmonary metastasis model, and finally evaluated the potential interaction between B7x and Neuropilin-1, a suggested potential cognate receptor. We showed that pro-inflammatory and anti-inflammatory cytokines IFNγ, TNFα, and IL-10 did not induce expression of B7x on human or murine cancer cells. Following i.v. injection of CT26, a murine colon cancer cell line in the BALB/c background, we observed a significant increase in tumor burden in the lung of B7x-expressing CT26 mice compared to B7x-negative parental CT26 control mice. This was marked by a significant increase in M2 tumor associated macrophages and antigen-specific CD8 T cell exhaustion. Finally, we found through multiple systems that there was no evidence for B7x and Neuropilin-1 direct interaction. Thus, the B7x pathway has an essential role in modulating the innate and adaptive immune cell infiltrate in the tumor microenvironment with its currently unknown cognate receptor(s).

摘要

B7x(B7-H4或B7S1)是B7免疫检查点配体家族的共抑制成员,与其未知的同源受体结合后可调节免疫功能。B7x在正常组织中表达有限,但在人类实体瘤中上调,以抑制抗肿瘤免疫,并与不良临床预后相关。我们评估了细胞因子刺激对癌细胞表面B7x表达的诱导作用,以及肿瘤表达的B7x在小鼠肺转移模型中的作用,最后评估了B7x与神经纤毛蛋白-1(一种潜在的同源受体)之间的潜在相互作用。我们发现促炎和抗炎细胞因子IFNγ、TNFα和IL-10不会诱导人或小鼠癌细胞上B7x的表达。在静脉注射BALB/c背景的小鼠结肠癌细胞系CT26后,我们观察到与B7x阴性的亲本CT26对照小鼠相比,表达B7x的CT26小鼠肺中的肿瘤负担显著增加。这表现为M2肿瘤相关巨噬细胞显著增加和抗原特异性CD8 T细胞耗竭。最后,我们通过多个系统发现没有证据表明B7x与神经纤毛蛋白-1直接相互作用。因此,B7x通路通过其目前未知的同源受体在调节肿瘤微环境中的先天性和适应性免疫细胞浸润方面具有重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/338f/5669925/0559bcf9534a/oncotarget-08-82740-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/338f/5669925/20d4ed4e290c/oncotarget-08-82740-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/338f/5669925/26c3d895cdd5/oncotarget-08-82740-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/338f/5669925/b2dfb0f89f90/oncotarget-08-82740-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/338f/5669925/60b60e89c3b1/oncotarget-08-82740-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/338f/5669925/a23277fd0649/oncotarget-08-82740-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/338f/5669925/0f844c033934/oncotarget-08-82740-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/338f/5669925/0559bcf9534a/oncotarget-08-82740-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/338f/5669925/20d4ed4e290c/oncotarget-08-82740-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/338f/5669925/26c3d895cdd5/oncotarget-08-82740-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/338f/5669925/b2dfb0f89f90/oncotarget-08-82740-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/338f/5669925/60b60e89c3b1/oncotarget-08-82740-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/338f/5669925/a23277fd0649/oncotarget-08-82740-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/338f/5669925/0f844c033934/oncotarget-08-82740-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/338f/5669925/0559bcf9534a/oncotarget-08-82740-g007.jpg

相似文献

1
Tumor-expressed immune checkpoint B7x promotes cancer progression and antigen-specific CD8 T cell exhaustion and suppressive innate immune cells.肿瘤表达的免疫检查点B7x促进癌症进展、抗原特异性CD8 T细胞耗竭以及抑制性固有免疫细胞。
Oncotarget. 2017 Sep 20;8(47):82740-82753. doi: 10.18632/oncotarget.21098. eCollection 2017 Oct 10.
2
Host b7x promotes pulmonary metastasis of breast cancer.宿主 b7x 促进乳腺癌肺转移。
J Immunol. 2013 Apr 1;190(7):3806-14. doi: 10.4049/jimmunol.1202439. Epub 2013 Mar 1.
3
Co-inhibitory Molecule B7 Superfamily Member 1 Expressed by Tumor-Infiltrating Myeloid Cells Induces Dysfunction of Anti-tumor CD8 T Cells.肿瘤浸润髓系细胞表达的共抑制分子 B7 超家族成员 1 诱导抗肿瘤 CD8 T 细胞功能障碍。
Immunity. 2018 Apr 17;48(4):773-786.e5. doi: 10.1016/j.immuni.2018.03.018. Epub 2018 Apr 3.
4
Tissue-expressed B7x affects the immune response to and outcome of lethal pulmonary infection.组织表达的 B7x 影响致死性肺部感染的免疫应答和结果。
J Immunol. 2012 Sep 15;189(6):3054-63. doi: 10.4049/jimmunol.1200701. Epub 2012 Aug 1.
5
B7x-from bench to bedside.B7x——从实验台到临床应用
ESMO Open. 2019 Sep 8;4(5):e000554. doi: 10.1136/esmoopen-2019-000554. eCollection 2019.
6
Wide Expression and Significance of Alternative Immune Checkpoint Molecules, B7x and HHLA2, in PD-L1-Negative Human Lung Cancers.B7x 和 HHLA2 等免疫检查点分子在 PD-L1 阴性人肺癌中的广泛表达及意义。
Clin Cancer Res. 2018 Apr 15;24(8):1954-1964. doi: 10.1158/1078-0432.CCR-17-2924. Epub 2018 Jan 26.
7
Immune Checkpoint B7x (B7-H4/B7S1/VTCN1) is Over Expressed in Spontaneous Canine Bladder Cancer: The First Report and its Implications in a Preclinical Model.免疫检查点B7x(B7-H4/B7S1/VTCN1)在自发性犬膀胱癌中过度表达:首例报告及其在临床前模型中的意义。
Bladder Cancer. 2019 Jan 31;5(1):63-71. doi: 10.3233/BLC-180204.
8
The B7x Immune Checkpoint Pathway: From Discovery to Clinical Trial.B7x 免疫检查点通路:从发现到临床试验。
Trends Pharmacol Sci. 2019 Nov;40(11):883-896. doi: 10.1016/j.tips.2019.09.008. Epub 2019 Oct 31.
9
B7 immune-checkpoints as targets for the treatment of neuroendocrine tumors.B7 免疫检查点作为神经内分泌肿瘤治疗的靶点。
Endocr Relat Cancer. 2021 Feb;28(2):135-149. doi: 10.1530/ERC-20-0337.
10
Structure and cancer immunotherapy of the B7 family member B7x.B7家族成员B7x的结构与癌症免疫治疗
Cell Rep. 2014 Nov 6;9(3):1089-98. doi: 10.1016/j.celrep.2014.09.053. Epub 2014 Oct 30.

引用本文的文献

1
Mapping Current Research Status and Emerging Frontiers of T-Cell Exhaustion: A Comprehensive Data-Mining-Based Study.绘制T细胞耗竭的当前研究现状与新兴前沿:一项基于全面数据挖掘的研究
Ann Surg Oncol. 2025 Aug 18. doi: 10.1245/s10434-025-18066-2.
2
sB7-H4 is a diagnostic biomarker in epithelial ovarian cancer and correlates to platinum resistance.可溶性B7-H4是上皮性卵巢癌的一种诊断生物标志物,与铂耐药相关。
Clin Exp Immunol. 2025 Jan 21;219(1). doi: 10.1093/cei/uxae084.
3
B7H4 Role in Solid Cancers: A Review of the Literature.B7H4在实体癌中的作用:文献综述

本文引用的文献

1
Tumor promoting role of anti-tumor macrophages in tumor microenvironment.抗肿瘤巨噬细胞在肿瘤微环境中的促肿瘤作用。
Cell Immunol. 2017 Jun;316:1-10. doi: 10.1016/j.cellimm.2017.04.005. Epub 2017 Apr 13.
2
Prognostic role of B7-H4 in patients with non-small cell lung cancer: A meta-analysis.B7-H4在非小细胞肺癌患者中的预后作用:一项荟萃分析。
Oncotarget. 2017 Apr 18;8(16):27137-27144. doi: 10.18632/oncotarget.15648.
3
Molecular Pathways: Evaluating the Potential for B7-H4 as an Immunoregulatory Target.分子途径:评估 B7-H4 作为免疫调节靶点的潜力。
Cancers (Basel). 2024 Jul 11;16(14):2519. doi: 10.3390/cancers16142519.
4
The role of CD8 T-cells in colorectal cancer immunotherapy.CD8 T细胞在结直肠癌免疫治疗中的作用。
Heliyon. 2024 Jun 15;10(12):e33144. doi: 10.1016/j.heliyon.2024.e33144. eCollection 2024 Jun 30.
5
Pancreatic Epithelial IL17/IL17RA Signaling Drives B7-H4 Expression to Promote Tumorigenesis.胰腺上皮细胞的 IL17/IL17RA 信号通路驱动 B7-H4 的表达,促进肿瘤发生。
Cancer Immunol Res. 2024 Sep 3;12(9):1170-1183. doi: 10.1158/2326-6066.CIR-23-0527.
6
B7H4 Expression Is More Frequent in MSS Status Colorectal Cancer and Is Negatively Associated with Tumour Infiltrating Lymphocytes.B7H4 表达在 MSS 状态结直肠癌中更为频繁,且与肿瘤浸润淋巴细胞呈负相关。
Cells. 2023 Mar 10;12(6):861. doi: 10.3390/cells12060861.
7
B7 Family Members in Pancreatic Ductal Adenocarcinoma: Attractive Targets for Cancer Immunotherapy.B7 家族成员在胰腺导管腺癌中的作用:癌症免疫治疗的有吸引力的靶点。
Int J Mol Sci. 2022 Nov 30;23(23):15005. doi: 10.3390/ijms232315005.
8
Potentiating effect of reovirus on immune checkpoint inhibition in microsatellite stable colorectal cancer.呼肠孤病毒对微卫星稳定型结直肠癌免疫检查点抑制的增强作用
Front Oncol. 2022 Oct 25;12:1018767. doi: 10.3389/fonc.2022.1018767. eCollection 2022.
9
Novel targets for immunotherapy associated with exhausted CD8 + T cells in cancer.癌症中与耗竭性CD8 + T细胞相关的免疫治疗新靶点。
J Cancer Res Clin Oncol. 2023 May;149(5):2243-2258. doi: 10.1007/s00432-022-04326-1. Epub 2022 Sep 15.
10
The immune checkpoint B7x expands tumor-infiltrating Tregs and promotes resistance to anti-CTLA-4 therapy.免疫检查点 B7x 扩增肿瘤浸润性 Tregs,并促进对抗 CTLA-4 治疗的耐药性。
Nat Commun. 2022 May 6;13(1):2506. doi: 10.1038/s41467-022-30143-8.
Clin Cancer Res. 2017 Jun 15;23(12):2934-2941. doi: 10.1158/1078-0432.CCR-15-2440. Epub 2017 Mar 21.
4
The third group of the B7-CD28 immune checkpoint family: HHLA2, TMIGD2, B7x, and B7-H3.B7-CD28免疫检查点家族的第三组:HHLA2、TMIGD2、B7x和B7-H3。
Immunol Rev. 2017 Mar;276(1):26-39. doi: 10.1111/imr.12521.
5
Novel B7-H4-mediated crosstalk between human non-Hodgkin lymphoma cells and tumor-associated macrophages leads to immune evasion via secretion of IL-6 and IL-10.新型B7-H4介导的人非霍奇金淋巴瘤细胞与肿瘤相关巨噬细胞之间的串扰通过分泌白细胞介素-6和白细胞介素-10导致免疫逃逸。
Cancer Immunol Immunother. 2017 Jun;66(6):717-729. doi: 10.1007/s00262-017-1961-7. Epub 2017 Feb 28.
6
Regulatory T cells, especially ICOS FOXP3 regulatory T cells, are increased in the hepatocellular carcinoma microenvironment and predict reduced survival.调节性T细胞,尤其是诱导共刺激分子(ICOS)FOXP3调节性T细胞,在肝细胞癌微环境中增多,并预示着生存期缩短。
Sci Rep. 2016 Oct 11;6:35056. doi: 10.1038/srep35056.
7
ICOS Promotes the Function of CD4+ Effector T Cells during Anti-OX40-Mediated Tumor Rejection.ICOS 促进抗 OX40 介导的肿瘤排斥过程中 CD4+效应 T 细胞的功能。
Cancer Res. 2016 Jul 1;76(13):3684-9. doi: 10.1158/0008-5472.CAN-15-3412. Epub 2016 May 4.
8
B7-H4(B7x)-Mediated Cross-talk between Glioma-Initiating Cells and Macrophages via the IL6/JAK/STAT3 Pathway Lead to Poor Prognosis in Glioma Patients.B7-H4(B7x)通过IL6/JAK/STAT3通路介导的胶质瘤起始细胞与巨噬细胞之间的串扰导致胶质瘤患者预后不良。
Clin Cancer Res. 2016 Jun 1;22(11):2778-2790. doi: 10.1158/1078-0432.CCR-15-0858. Epub 2016 Mar 21.
9
Ablation of Neuropilin 1 from glioma-associated microglia and macrophages slows tumor progression.从胶质瘤相关的小胶质细胞和巨噬细胞中去除神经纤毛蛋白1可减缓肿瘤进展。
Oncotarget. 2016 Mar 1;7(9):9801-14. doi: 10.18632/oncotarget.6877.
10
Emerging targets in cancer immunotherapy: beyond CTLA-4 and PD-1.癌症免疫疗法中的新兴靶点:超越CTLA-4和PD-1
Immunotherapy. 2015;7(11):1169-86. doi: 10.2217/imt.15.78. Epub 2015 Nov 16.